---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-014142"
form_type: "8-K"
ticker: "XOMA"
cik: "0000791908"
company_name: "XOMA Royalty Corp"
filed_at: "2026-01-15T23:59:59+00:00"
generated_at: "2026-05-16T10:17:48.244822+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# XOMA Royalty names Jeffrey Trigilio CFO; Thomas Burns departs after ~19 years

## Summary
- Thomas Burns stepped down as CFO effective Jan 12, 2026; separation agreement includes $16k/month consulting for 3 months.
- Jeffrey Trigilio appointed CFO effective Jan 12; was CFO/COO at Obsidian Therapeutics and CFO at Cullinan Therapeutics.
- Trigilio receives $515k base salary, 40% target bonus, initial grant of 30,000 performance units, and annual equity grant in 2026.
- Severance for Trigilio: 0.75x base salary, pro-rated bonus, 9-month health benefits; doubled to 1.5x base+bonus on change of control.

## SEC filing metadata
- accession: 0001193125-26-014142
- form_type: 8-K
- ticker: XOMA
- cik: 0000791908
- company_name: XOMA Royalty Corp
- filed_at: 2026-01-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/791908/000119312526014142/0001193125-26-014142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/791908/000119312526014142/d59764d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-014142
- JSON: https://secwatch.observer/filing/0001193125-26-014142.json
- Plain text: https://secwatch.observer/filing/0001193125-26-014142.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.